Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K2PD
|
|||
Former ID |
DNC000058
|
|||
Drug Name |
3-aminobenzamide
|
|||
Synonyms |
3-Aminobenzamide; 3544-24-9; m-Aminobenzamide; Benzamide, 3-amino-; 3-Amino-benzamide; Benzamide, m-amino-; meta-aminobenzamide; 3-ABA; 3-Aminobenzimide; 3-amino benzamide; aniline-3-carboxamide; 3-aminobenzoic acid amide; UNII-8J365YF1YH; CCRIS 3925; EINECS 222-586-9; NSC 36962; BRN 2802373; PARP Inhibitor I, 3-ABA; 3-H2NC6H4CONH2; CHEMBL81977; 3-AB; 8J365YF1YH; CHEBI:64042; GSCPDZHWVNUUFI-UHFFFAOYSA-N; MFCD00007989; 3-Aminobenzamide, 98%; SR-01000075657; HSDB 7581; 3-azanylbenzamide; m-amino benzamide; 4pml; 3-Aminobenzaminde
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
Structure |
Download2D MOL |
|||
Formula |
C7H8N2O
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)N)C(=O)N
|
|||
InChI |
1S/C7H8N2O/c8-6-3-1-2-5(4-6)7(9)10/h1-4H,8H2,(H2,9,10)
|
|||
InChIKey |
GSCPDZHWVNUUFI-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 3544-24-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
93448, 623913, 3153929, 5671792, 8001804, 8150037, 8151216, 10519884, 11110713, 11113706, 11120346, 11120834, 11121322, 11121497, 11121977, 11335892, 11361131, 11362566, 11364386, 11364767, 11365128, 11366948, 11367329, 11367690, 11369510, 11369891, 11370403, 11370404, 11371922, 11372931, 11373291, 11374650, 11375491, 11375852, 11377672, 11378056, 11462103, 11485250, 11489393, 11490787, 11492910, 11495306, 12034999, 15090915, 17404607, 22391541, 24278206, 24855089, 26679244, 26751894
|
|||
ChEBI ID |
CHEBI:64042
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase 1 (PARP1) | Target Info | Inhibitor | [1], [2] |
KEGG Pathway | Base excision repair | |||
NF-kappa B signaling pathway | ||||
Panther Pathway | FAS signaling pathway | |||
Pathway Interaction Database | Integrin-linked kinase signaling | |||
Caspase Cascade in Apoptosis | ||||
Notch-mediated HES/HEY network | ||||
Reactome | Dual Incision in GG-NER | |||
WikiPathways | FAS pathway and Stress induction of HSP regulation | |||
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | ||||
Nanoparticle triggered regulated necrosis | ||||
Corticotropin-releasing hormone |
References | Top | |||
---|---|---|---|---|
REF 1 | Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med. 2001 Jan;7(1):108-13. | |||
REF 2 | Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeras... J Med Chem. 1998 Dec 17;41(26):5247-56. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.